Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
October 02 - 03, 2025
Sheraton San Diego Hotel & Marina, San Diego, CA
Sponsor Register
About Attend Partner What's On
Live Now Button (3)

Uniting North American biopharma leaders to accelerate proteins, antibodies and ADCs discovery & development

October 02 - 03, 2025
Sheraton San Diego Hotel & Marina, San Diego, CA, USA

Now: Afternoon Sessions

Follow along live as industry leaders unveil the latest advancements in biomedicine. 

15:05

Panel Discussion: NextGen Vaccine Strategies To Advance Cancer Treatment
Moderator: ANTONIO POSTIGO, Chief Scientific Officer, Stratosvir Ltd

Panel Discussion: The Next Chapter Of Oligonucleotide Delivery
Moderator: STEVE HOOD, Senior Director, Oligonucleotide ADME Strategy, DMPK, GSK

Empowering Antibody Engineering – Highlights From Early Beginnings Of Using AI-Based Tools For Optimization & Functional Engineering Of Antibody Candidates
BERIT OLSEN KROGH, Senior Research Fellow, Lundbeck

Panel Discussion: Mixed Modalities: Addressing The Challenges & Opportunities To Drug The Undruggable

Multivalent Ligand Design To Selectively Bind Proteins
NATHAN ALVES, Research Director, Indiana University School Of Medicine

15:30

Cyclotides As Ultra-Stable Combinatorial Display Platforms For Peptide-Based Drug Discovery
DAVID CRAIK, Professor, University Of Queensland

Enhancing Biologics Lead Optimisation By Combining Affinity Prediction Methods & Active Learning
OWEN VICKERY, Associate Principal Scientist, AstraZeneca

InSiDe Out: In Silico Developability Screening At AstraZeneca, Impact To Date & Future Direction
ISABELLE SERMADIRAS, Associate Principal Scientist, AstraZeneca

15:55

Unveiling Hidden Targets: AI-Driven Discovery Of Therapeutic Cancer Antigens From The Dark Genome
CHRISTIAN GARDE, Director, Evaxion

The Identification Of Cyclic Peptide Metabolic Soft Spots By Isotope-Labelled Reductive Dimethylation & Leveraging High-Resolution Ion Mobility-Mass Spectrometry
MARIA FAWAZ, Associate Principal Scientist, MS

Using The Very Small To Tackle The Very Large – Our Journey From Concept To Clinic
IJEOMA UCHEGBU, Professor Of Pharmaceutical Nanoscience, University College London

First-In-Class Site-Directed Targeted soloMER Drug Conjugate For Autoimmune Inflammation
OBINNA UBAH, Principal Scientist, Elasmogen

Rationalising MABs Developability Testing
DAVID BROCKWELL, Professor, University Of Leeds

16:20

Development & Qualification Of A Cell-Based Potency Assay For Two Novel DNA Cancer Vaccine
ELISA MARELLI, Research Scientist, Scancell

Short Novel Peptides As Chelating Agents For Metal-Related Diseases
MICHAL SHOSHAN, Founder & Chief Executive Officer, metaLead Therapeutic

Purification Of Oligonucleotides & Their Conjugates For Progressing Early Drug Discovery Projects & The Chromatographic Challenges With Oligonucleotide G-rich Sequences
YIPING WU, Senior Scientist, AstraZeneca

Removing Biological Roadblocks To Better Treatments: The Power Of Nanofitin-Enhanced Biologics
MATHIEU CINIER, Scientific Director, Affilogi

Share Your NextGen Biomed Moments

We'd love to see your favourite moments and photos on social media! Use the hashtags #NextGenBiomed2025 and #NGB2025, and tag our official accounts below.

Together, we can accelerate life-saving treatments at scale

Biologics US 2025 brings together leaders in biologics R&D through two focused programs on one dynamic platform. Over two immersive days, the event spotlights breakthrough innovations in proteins, antibodies, and the development of antibody-drug conjugates (ADCs).

Attendees will delve into the latest advances in biologics & ADC's research, therapeutic optimization, and ADC manufacturing strategies. With collaboration at its core, Biologics US fosters meaningful partnerships, cross-disciplinary alignment, and actionable insights—empowering the community to transform novel science into life-changing treatments for patients.

Explore the Biologics US Programs

Antibody Society

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society

Biologics Icon NGB Square

About

Discover more about our ecosystem of channels for the biologics R&D community

Biologics US Attend Square

Attend

Be part of the new wave of Biomed R&D innovation

Partnerships Stock

Partner

Showcase your offering to leading pharma and biotech decision makers

What's On

What's On

Explore dynamic panels, engaging roundtables, and hands-on workshops

NextGen Biomed 2025 Programme Highlights

Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:

Proteins, Antibodies & ADCs
Panel Discussion: What Is The Next Game Changer In Antibody Engineering?

Moderator: Karen Silence, Head Preclinical Product Development, ArgenX
Panellists include Berit Olsen Krogh, Senior Research Fellow, Lundbeck; Andrew Buchanan, Principal Scientist, AstraZeneca

Peptides
Presentation: What Does The Future Hold For Orally Available Peptides?

Presented by: Immanuel Lerner, Chief Executive Officer, 
Pepticom

Oligonucleotides
Panel Discussion: The Next Chapter Of Oligonucleotide Delivery

Moderator: Steve Hood, Senior Director, Oligonucleotide ADME Strategy, GSK
Panellists include 

Saul Martinez Montero, Senior Director, RNA Therapeutics, Dyne Therapeutics
Morten Lindow, RNAHub Founder & Mission Lead, Roche
Sritama Bose, Head Of Chemistry Research & Innovation, NATA
Fazel Shabanpoor, Co-Founder & Chief Scientific Officer & Associate Professor & Head Of Pep & Oligo Therapeutics Lab, Centron Bio & The Florey Institute

 

Sustainability in Tides & Biologics
Panel Discussion: Navigating The Paradigm Shift Towards Greener Approaches

Moderator: Walter Cabri, Full Professor of Organic Chemistry, University of Bologna
Panellists include Daniel Sejer Pedersen, Chemical Development Specialist CMC API Development, Novo Nordisk;
Anna Maria Papini, Full Professor & Group Leader, University of Florence;
Louis Diorazio, Senior Principal Scientist, New Modalities, AstraZeneca;
Alessandra Tolomelli, Associate Professor, University of Bologna

Immunotherapy & Immuno-oncology
Presentation: How Vaccines & Immunotherapy Strategies: Converging Pathways For Preventing Or Treating Chronic Diseases

Presented by: Daniel Larocque, Innovation Lead, Innovation & Emerging Science, Sanofi

Key Event Highlights

An unmissable journey awaits you: from celebrated keynote speakers and insightful fireside chats, to an exclusive gala dinner at London's Science Museum. Discover the moments that will transform your NextGen Biomed experience. 

Meet Our Expert Speakers

Bishnu Nayak
Sr Director,
NeologicsBio
Dana Filoti
Associate Director,
AbbVie
Harpinder Saini
Sr. Scientist,
Genentech
Hetal Sarvaiya
Associate Director, DMPK-BA,
AbbVie
Peter Ihnat
Director Protein Biochemistry,
Regeneron
Ryan Stafford
Executive Director Of Protein Engineering,
3T Biosciences
A. James Link
Associate Professor of Chemical and Biological Engineering,
Princeton University
Arkadi Manukyan
Senior Scientist,
SANOFI
Eric Janezic
Principal Scientist,
Genentech
Julio Camarero
Professor, Pharmacology and Pharmaceutical Sciences,
University of Southern California
Maral Adeli Koudehi
Sr Scientist,
Johnson & Johnson
Nathan Alves
Research Director,
Indiana University School of Medicine
Priya Ganesan
Senior Scientist,
Amgen
Purbasa Patnaik
Associate Director,
Exelixis
Ray Huang
Scientist,
Macrogenics
Sandeep Chhabra
Principal Scientist/Group Lead,
Amgen
Sheila Singh
Professor,
McMaster University
Siva Devanaboyina
Scientist,
Amgen
Twinkle Christian
Senior principal scientist,
Amgen
Wenyu Liu
Senior Scientist,
Genentech
Yang Hu
Scientist,
Regeneron
GenScript

The 1-2-1s are the best thing about Oxford Global events, well organised and good number of relevant contacts. Good high level contacts from big companies.

 

Advanced Therapies Specialist Team Leader,
Genscript

Biosystems Acro

Biologics 2024 has been one of the best events I have attended so far in my career.

 

Territorial Sales Manager UK,
ACROBiosystems Co., Ltd.

Bioassay

 

Impressed by the effort to bring people together.

 

Business Development Director,

Bioassay

IpA

 

Nice set-up, with good support for exhibitors

 

Director of Client Relations,

ImmunoPrecise

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

In-Person Services Digital Marketing Services

Interested in Sponsoring Biologics US?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. Biologics US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Find Out More

2025 Sponsors Include

Register Now

Be part of the new wave of Biomed R&D innovation,

Partner with us

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients